论文部分内容阅读
为探讨糖尿病肾病(DN)患者血清内脂素水平变化及其在发病中的可能作用,笔者测定了糖尿病患者血清内脂素水平,现报道如下.1资料与方法1.1一般资料按WHO诊断标准选择2008-06-2009-06在本院内分泌科住院的2型糖尿病患者106例,按国际通用的Mogense DN分期标准将其分为无DN组(正常白
In order to investigate the changes of serum visfatin levels in patients with diabetic nephropathy (DN) and its possible role in the pathogenesis, the author measured the serum visfatin levels in patients with diabetes mellitus, are reported as follows.1 Materials and Methods 1.1 General Information According to the WHO diagnostic criteria One hundred and sixty six patients with type 2 diabetes who were hospitalized in Department of Endocrinology of our hospital from June 2008 to June 2009 were divided into four groups according to the internationally accepted Mogense DN staging criteria: